Citizens Financial Group Inc. RI purchased a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the second quarter, Holdings Channel reports. The institutional investor purchased 2,893 shares of the semiconductor company’s stock, valued at approximately $1,290,000.
Other hedge funds have also bought and sold shares of the company. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of Synopsys during the 2nd quarter valued at $747,400,000. China Universal Asset Management Co. Ltd. grew its holdings in Synopsys by 31.8% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company’s stock worth $6,957,000 after purchasing an additional 3,575 shares during the period. Norges Bank bought a new stake in Synopsys in the fourth quarter valued at $730,197,000. SBI Okasan Asset Management Co.Ltd. acquired a new stake in shares of Synopsys in the 4th quarter valued at about $1,699,000. Finally, Mizuho Markets Americas LLC bought a new stake in Synopsys in the 1st quarter valued at about $20,182,000. Institutional investors own 85.47% of the company’s stock.
Synopsys Trading Down 2.1%
Shares of Synopsys stock opened at $404.41 on Wednesday. The company has a market capitalization of $77.44 billion, a P/E ratio of 93.61, a price-to-earnings-growth ratio of 2.48 and a beta of 1.23. The stock has a fifty day simple moving average of $423.21 and a 200 day simple moving average of $441.54. Synopsys, Inc. has a 12-month low of $366.00 and a 12-month high of $624.82. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33.
Analysts Set New Price Targets
Several brokerages have issued reports on SNPS. Robert W. Baird set a $558.00 price target on Synopsys in a report on Thursday, May 28th. Benchmark started coverage on Synopsys in a report on Wednesday, July 15th. They set a “buy” rating and a $570.00 price objective for the company. Zacks Research raised Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. KeyCorp reiterated an “overweight” rating on shares of Synopsys in a report on Thursday, May 28th. Finally, Morgan Stanley lifted their price target on shares of Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a research report on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Synopsys currently has a consensus rating of “Moderate Buy” and an average price target of $565.06.
View Our Latest Stock Report on Synopsys
Insider Activity at Synopsys
In related news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This trade represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.56% of the company’s stock.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
